Abstract
Simple measures of type I interferon (IFN) activity constitute highly attractive biomarkers in systemic lupus erythematosus (SLE). We explore galectin-3-binding protein (G3BP) as a novel measure of type I IFN activity and serum/plasma biomarker in large independent cohorts of patients with SLE and controls.
Original language | English |
---|---|
Pages (from-to) | e000026 |
Journal | Lupus science & medicine |
Volume | 1 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2014 |
Subject classification (UKÄ)
- Rheumatology and Autoimmunity